Recombinant multi-species SERF1B protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine SERF1B protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene is part of a 500 kb inverted duplication on chromosome 5q13. This duplicated region contains at least four genes and repetitive elements which make it prone to rearrangements and deletions. The repetitiveness and complexity of the sequence have also caused difficulty in determining the organization of this genomic region. This gene is the centromeric copy which is identical to the telomeric copy. Alternatively spliced transcripts have been documented but it is unclear whether alternative splicing occurs for both the centromeric and telomeric copies of the gene. The gene encodes a protein of unknown function which bears low-level homology with the RNA-binding domain of matrin-cyclophilin, a protein which colocalizes with small nuclear ribonucleoproteins (snRNPs) and the SMN1 gene product. [provided by RefSeq, Jul 2008]
The Alternative Names of target: 4F5,FAM2B,H4F5C,Msmac1,Protein 4F5 (h4F5),SERF1,SERF1A,SERF1B,SMA modifier 1,Serf1,Small EDRK-rich factor 1,h4F5,m4F5

Target products collectionGo to SERF1B products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP1611-Ag-1/ GM-Tg-hg-IP1611-Ag-2 Human SERF1B protein Human
GM-Tg-rg-IP1611-Ag-1/ GM-Tg-rg-IP1611-Ag-2 Rat SERF1B protein Rat
GM-Tg-mg-IP1611-Ag-1/ GM-Tg-mg-IP1611-Ag-2 Mouse SERF1B protein Mouse
GM-Tg-cynog-IP1611-Ag-1/ GM-Tg-cynog-IP1611-Ag-2 Cynomolgus/Rhesus macaque SERF1B protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP1611-Ag-1/ GM-Tg-felg-IP1611-Ag-2 Feline SERF1B protein Feline
GM-Tg-cang-IP1611-Ag-1/ GM-Tg-cang-IP1611-Ag-2 Canine SERF1B protein Canine
GM-Tg-bovg-IP1611-Ag-1/ GM-Tg-bovg-IP1611-Ag-2 Bovine SERF1B protein Bovine
GM-Tg-equg-IP1611-Ag-1/ GM-Tg-equg-IP1611-Ag-2 Equine SERF1B protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP1611-Ag-1/ GM-Tg-hg-IP1611-Ag-2; GM-Tg-rg-IP1611-Ag-1/ GM-Tg-rg-IP1611-Ag-2;
GM-Tg-mg-IP1611-Ag-1/ GM-Tg-mg-IP1611-Ag-2; GM-Tg-cynog-IP1611-Ag-1/ GM-Tg-cynog-IP1611-Ag-2;
GM-Tg-felg-IP1611-Ag-1/ GM-Tg-felg-IP1611-Ag-2; GM-Tg-cang-IP1611-Ag-1/ GM-Tg-cang-IP1611-Ag-2;
GM-Tg-bovg-IP1611-Ag-1/ GM-Tg-bovg-IP1611-Ag-2; GM-Tg-equg-IP1611-Ag-1/ GM-Tg-equg-IP1611-Ag-2
Products Name SERF1B protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name SERF1B
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine SERF1B protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.